Japanese Korean Chinese - Traditional Chinese - Simplified 

Conference Menu

Current Event 

Overview
Register 
PDF Download
Day 1
Day 2 
Short Course
Posters 
Hotel & Travel 
Sponsor & Exhibits 
Press Pass 
Request Brochure 
Archives 

Add To Outlook 

Corporate Sponsors


Comprehensive Biomarker Center

Firefly
 

Ingenuity

NanoString 

 

Official Media Partner

Bio-IT World 

Media Partners

BioPortfolio 

DrugDiscoveryNews 

eCliniqua 

FierceBiotech 

Genetic Engineering News  

Genome Technology 

Insight Pharma Reports 

labroots.com 

MIRNA blog 

MRN Dx and Therapeutics Journal 

NGS Leaders 

PharmaVoice 

 

Science AAAS logo 

The Scientist 

Technology Networks 


DVD logo 


microRNA: Targets and Tools for Therapeutic Development

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!
2013 Archived Content

Mark Your Calendar! The 10th Annual microRNA Conference will be held March 17-18, 2014 at the Omni Parker House in Boston, MA.

microRNAs are playing an important role in a range of diseases such as cancer, metabolic diseases and cardiovascular disorders. Their involvement in many physiological pathways, makes them an excellent target for pharmaceutical drug development and their use as biomarkers or for profiling and screening turns them into a valuable tool for diagnostics. This conference highlights the latest developments in using miRNA's for health and disease, the novel applications and progress made in manipulating microRNA, and the opportunities for using microRNA as a tool.

20+ SCIENTIFIC PRESENTATIONS COVERING: 

  • Therapeutic Potential in Inflammation, Cancer and Pain
  • New Technological Strategies
  • microRNAs as Biomarkers and in Diagnostics
  • Tissue-Based Analysis
  • Circulating miRNAs

SHORT COURSE: 

Sunday, March 3
2:00 - 5:00 pm Computational Aspects of microRNA 

Computational Analysis of Noncoding RNA

Stefan Washietl, Ph.D., Scientist, Computational Biology, Massachusetts Institute of Technology

Using a Bioinformatics Resource Manager

Susan C. Tilton, Ph.D., Scientist, Computational Biology & Bioinformatics, Pacific Northwest National Laboratory

BioVLAB-MMIA: a Cloud Environment for microRNA and mRNA Integrated Analysis (MMIA) on Amazon EC2

Hyungro Lee, Ph.D., Pervasive Technology Institute, School of Informatics and Computing, Indiana University
 

AGENDA HIGHLIGHTS: 

microRNAs in Diagnostics and Targeting Rheumatic Disease

Steffen Gay, M.D., Professor, Experimental Rheumatology, University of Zurich

Causes and Consequences of microRNA Dysregulation in Cancer

Carlo M. Croce, M.D., Professor and Chair, Department of Molecular Virology, Immunology and Medical Genetics; Director, Institute of Genetics,Ohio State University

Pre-Clinical Development of a Tumor Suppressor miRNA

David Brown, Ph.D., Director, Research, Mirna Therapeutics

microRNAs: Novel Target Class for Small Molecule Drug Discovery?

Pramod Pandey, Ph.D., Senior Research Investigator, Center for Proteomic Chemistry, Integrated Lead Discovery, Novartis Institute for Biomedical Research, Inc.

Circulating miRNAs as Biomarkers: How Far Have We Made It?

Igor Mikaelian, M.D., D.V.M., MSc, DACVP, Research Leader, Hoffman-La Roche, Inc.

Extracting Contextual microRNA Information for Cancer Diagnostics

Lorenzo F. Sempere, Ph.D., Research Assistant Professor, Department of Medicine, Geisel School of Medicine at Dartmouth





By Series:
By Region: